Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-027-5 | CAS number: 68171-38-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Effects on developmental toxicity
Description of key information
Oral (read across, OECD 414, rat): NOAEL maternal systemic ≥ 1000 mg/kg bw/day
Oral (read across, OECD 414, rat): NOAEL development ≥ 1000 mg/kg bw/day
The hazard assessment is based on the data currently available. New studies with the registered substance and/or other member substances of the glycol esters category will be conducted in the future. The finalised studies will be included in the technical dossier as soon as they become available and the hazard assessment will be re-evaluated accordingly.
For further details, please refer to the category concept document attached to the category object (linked under IUCLID section 0.2) showing an overview of the strategy for all substances within the glycol esters category.
Link to relevant study records
- Endpoint:
- developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- Summary of available data used for the endpoint assessment of the target substance
- Adequacy of study:
- key study
- Justification for type of information:
- refer to analogue justification provided in IUCLID section 13
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- maternal toxicity rat
- Effect level:
- >= 2 500 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Basis for effect level:
- other: no adverse effects observed
- Remarks on result:
- other: Source CAS 85883-73-4
- Key result
- Abnormalities:
- no effects observed
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- embryotoxicity/teratogenicity rat
- Effect level:
- >= 2 500 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no adverse effects observed
- Remarks on result:
- other:
- Remarks:
- Source: CAS 85883-73-4
- Key result
- Abnormalities:
- no effects observed
- Key result
- Developmental effects observed:
- no
- Conclusions:
- The read across approach is justified in the analogue justification. The target and source substances are considered unlikely to differ in their developmental toxicity potential. In three developmental toxicity studies in rats with a) Fatty acids, C6-12, esters with propylene glycol (CAS 85883-73-4), b) Decanoic acid, mixed esters with octanoic acid and propylene glycol (CAS 68583-51-7), and c) Fatty acids, C16-18, esters with ethylene glycol (CAS 91031-31-1) no developmental effects were observed. The NOAELS were greater than the highest doses tested (≥900 mg/kg/day). Therefore no developmental toxicity is expected for target substance isooctadecanoic acid, monoester with propane-1,2-diol (CAS 68171-38-0).
Reference
Data from the source substance propylene glycol monocaprylate (CAS 85883-73-4) were selected as key results for reasons of structural similarity and data reliability.
Additional developmental toxicity data were available for the source substance Decanoic acids, mixed diesters with octanoic acid and propylenglycol (CAS 68583-51-7) and Fatty acids, C16-18; ester with ethylenglycol (CAS 91031-31-1). Both substances were tested according to OECD guideline 414 in rats. In both studies the highest tested dose 1000 mg/kg bw/day and 900 mg/kg bw/day were found to be the resulting developmental NOAEL.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The available information comprises adequate and reliable (Klimisch score ≤2) studies from reference substances with similar structure and intrinsic properties. Read-across is justified based on common precursors and breakdown products of hydrolysis and consistent trends in environmental fate, eco-toxicological and toxicological profile (refer to the endpoint discussion for further details). The selected studies are thus sufficient to fulfil the standard information requirements set out in Annex VIII-IX, 8.7, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006.
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
The hazard assessment is based on the data currently available. New studies with the registered substance and/or other member substances of the glycol esters category will be conducted in the future. The finalised studies will be included in the technical dossier as soon as they become available and the hazard assessment will be re-evaluated accordingly.
For further details, please refer to the category concept document attached to the category object (linked under IUCLID section 0.2) showing an overview of the strategy for all substances within the glycol esters category.
Developmental toxicity/ teratogenicity
CAS 85883-73-4
A prenatal developmental toxicity GLP study (key study, 2007) was performed according to OECD guideline 414 with propylene glycol monocaprylate (CAS 85883-73-4). 25 female Sprague-Dawley rats/dose were dosed once daily by oral gavage during gestational days 6-17 with 0 (water control), 500, 1500 and 2500 mg/kg bw/day of the neat test substance. Maternal examinations comprised twice daily cage side observations, daily clinical observations, body weight and feed consumption on GD 0, 6-18 (daily), and 20 and necropsy with macroscopic examinations on GD 20. The ovaries and uterine content was examined for gravid uterus weight, number of corpora lutea, number of implantations, number of early resorptions and number of late resorptions. Fetal examinations comprised external examinations, soft tissue examinations, skeletal examinations, and head examinations.
Based on the absence of adverse effects on maternal toxicity, maternal developmental toxicity and foetuses the NOAEL for developmental toxicity/teratogenicity and for maternal developmental toxicity in rats was ≥ 2500 mg/kg bw/day.
CAS 68583-51-7
A prenatal developmental toxicity GLP study (supporting study 1994) was performed according to OECD guideline 414 with Decanoic acids, mixed diesters with octanoic acid and propylenglycol (CAS 68583-51-7). 24 female Sprague-Dawley rats/dose were dosed once daily by oral gavage during gestational days 6-15 with 0 (vehicle control), 100, 300 and 1000 mg/kg bw/day of the test substance in arachis oil. Maternal examinations comprised twice daily clinical observations, body weight determination on GD 0, 6, 16, and 20 and necropsy with macroscopic examinations on GD 20. The ovaries and uterine content was examined for gravid uterus weight, number of corpora lutea, number of implantations, number of early resorptions and number of late resorptions. Foetal examinations comprised external examinations, soft tissue examinations, skeletal examinations, and head examinations.
Based on the absence of adverse effects on maternal toxicity, maternal developmental toxicity and foetuses, the NOAEL for developmental toxicity/teratogenicity and for maternal developmental toxicity in rats was ≥1000 mg/kg bw/day.
CAS 91031-31-1
A prenatal developmental toxicity GLP study (supporting study, 1997) was performed according to OECD guideline 414 with Fatty acids, C16-18; ester with ethylene glycol (CAS 91031-31-1). 24 female Sprague-Dawley rats/dose were dosed once daily by oral gavage during gestational days 6-15 with 0 (vehicle control), 100, 300 and 900 mg/kg bw/day of the test substance in 0.5% sodium carboxymethylcellulose and 0.25% Cremophor in aqua dest. as vehicle. Maternal examinations comprised twice daily cage side observations and clinical observations, body weight on GD 0, 6, 16, and 20 and necropsy with macroscopic examinations on GD 20. The ovaries and uterine content was examined for gravid uterus weight, number of corpora lutea, number of implantations, number of early resorptions and number of late resorptions. Foetal examinations comprised external examinations, soft tissue examinations, skeletal examinations, and head examinations.
Based on the absence of adverse effects on maternal toxicity, maternal developmental toxicity and foetuses the NOAEL for developmental toxicity/teratogenicity and for maternal developmental toxicity in rats was ≥ 900 mg/kg bw/day.
Overall conclusion for developmental toxicity/teratogenicity
Analogue read-across from source substances was applied for the developmental toxicity /teratogenicity endpoint. No effects on reproductive parameters/organs were observed in the available prenatal developmental toxicity studies. The NOAEL for developmental toxicity was at the limit dose of 1000 mg/kg bw/day. Based on the available data and following the analogue approach, absence of adverse effects on fertility is expected for the target substance Isooctadecanoic acid, monoester with propane-1,2 -diol (CAS 68171 -38 -0).
Justification for classification or non-classification
According to Article 13 of Regulation (EC) No. 1907/2006 "General Requirements for Generation of Information on Intrinsic Properties of substances", information on intrinsic properties of substances may be generated by means other than tests e.g. from information from structurally related substances (grouping or read-across), provided that conditions set out in Annex XI are met. Annex XI, "General rules for adaptation of this standard testing regime set out in Annexes VII to X” states that “substances whose physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity may be considered as a group, or ‘category’ of substances. This avoids the need to test every substance for every endpoint". Since the analogue concept is applied to Isooctadecanoic acid, monoester with propane-1,2-diol (CAS 68171-38-0), data will be generated from data for reference source substance(s) to avoid unnecessary animal testing. Additionally, once the analogue read-across concept is applied, substances will be classified and labelled on this basis. Based on the analogue read-across approach, the available data on toxicity to reproduction does not meet the classification criteria according to Regulation (EC) 1272/2008 or Directive 67/548/EEC, and is therefore conclusive but not sufficient for classification.
Therefore, based on the analogue read-across approach, the available data on reproduction toxicity do not meet the classification criteria according to Regulation (EC) 1272/2008 and are therefore conclusive but not sufficient for classification.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.